News Category: Advocacy

CMS released its annual monitoring report[link] on the Medicare Part B Home Infusion Therapy (HIT) Services benefit showing that both provider participation and beneficiary utilization have declined over the past year.
The National Home Infusion Association (NHIA) has developed recommendations for commercial, Medicaid, and Medicare Advantage payors to improve patient outcomes and experience, reduce administrative burden, and improve timely access to home infusion services.
This week, during a House Energy and Commerce Health Subcommittee hearing on Health Care Spending in the United States, Rep. Debbie Dingell (D-MI) addressed Medicare costs and the potential for home infusion to lead to significant cost savings.

CMS Releases 2024 HIT Monitoring Report

CMS released its annual monitoring report[link] on the Medicare Part B Home Infusion Therapy (HIT) Services benefit showing that both provider participation and beneficiary utilization have declined over the past year.

Read More »

A Retrospective Descriptive Study of Remdesivir Treatment in the Home or Outpatient Setting Among Adult Patients Diagnosed with Coronavirus Disease 2019 (COVID-19)

Full text | Download pdf

Julia K. Nguyen, PharmD Kaiser Permanente, Southern California Home Infusion Pharmacy | Rulin Hechter, MD, PhD, MS Kaiser Permanente, Department of Research and Evaluation, Southern California Permanente Medical Group, Kaiser Permanente Bernard J. Tyson School of Medicine, Department of Health Systems Science | Deborah Ling Grant, PhD, MPH, MBA Kaiser Permanente Department of Research and Evaluation, Southern California Permanente Medical Group | Jiaxiao Shi, PhD Kaiser Permanente Department of Research and Evaluation, Southern California Permanente Medical Group | Cecilia Portugal, MPH Kaiser Permanente Department of Research and Evaluation, Southern California Permanente Medical Group | William J. Towner, MD Kaiser Permanente Department of Research and Evaluation, Southern California Permanente Medical Group, Kaiser Permanente Bernard J. Tyson School of Medicine, Department of Health Systems Science, Kaiser Permanente Southern California Infectious Diseases Clinic

At the onset of the COVID-19 pandemic, early conflicting evidence complicated implementation of therapy.

Read More »

A Retrospective Quality Improvement Study of Pharmacist-Directed Vancomycin Dosing Among Adult Home Infusion Patients

Full text | Download pdf

Claire Meredith, PharmD, CarepathRx | Leita Frey, PharmD, BCPS, CarepathRx, | Shelby George, PharmD, CarepathRx | Megan K. Zielke, PharmD, BCCCP, CarepathRx

Vancomycin is widely used to treat gram-positive infections. Vancomycin therapy is accompanied by the clinical monitoring of trough levels in order to maintain therapeutic efficacy and patient safety.

Read More »

NHIA Releases 2024 Commercial Payor Recommendations

The National Home Infusion Association (NHIA) has developed recommendations for commercial, Medicaid, and Medicare Advantage payors to improve patient outcomes and experience, reduce administrative burden, and improve timely access to home infusion services.

Read More »

Home Parenteral Nutrition Patient Experience and Clinical Outcomes

Full text | Download pdf

Michelle Simpson, PharmD, BCSCP, MWC, Clinical Program Manager and Editor-in-Chief, Infusion Journal at National Home Infusion Association; Danell Haines, PhD, D.J., Haines Research Consulting

Parenteral nutrition is a complex infusion therapy that impacts a patient’s health and well-being. The National Home Infusion Foundation (NHIF) collects data on the home parenteral nutrition (HPN) patient population. Quality measures monitored through two NHIF benchmarking programs provide data from patient satisfaction surveys and rates of hospital readmission within the first 30 days of home infusion services.

Read More »

NHIF Announces Finalists for 2024 Outstanding Abstract Achievement Award

The National Home Infusion Foundation (NHIF) announces the finalists for its Outstanding Abstract Achievement Award for 2024. The authors of the following 5 poster abstracts will present an overview of their research project and summarize their findings during a special clinical webinar and a panel of judges will select the award recipient.

Read More »

NHIA Announces 2024-2025 Board of Directors

The National Home Infusion Association (NHIA) is proud to announce its 2024-2025 Board of Directors. Beginning this term, the association expanded to 17 the number of board seats on its governing body to provide a broader diversification of infusion provider organizations.

Read More »

NHIA Announces 2024 Class of Fellows

The National Home Infusion Association (NHIA) is pleased to announce the 2024 Fellow Program (FNHIA) cohort, made up of highly accomplished home and alternate site infusion professionals.
The prestigious NHIA Fellow Program aims to advance the home and alternate site infusion profession by recognizing the contributions and achievements of highly accomplished individuals.

Read More »

CMS Releases 2024 HIT Monitoring Report

CMS released its annual monitoring report[link] on the Medicare Part B Home Infusion Therapy (HIT) Services benefit showing that both provider participation and beneficiary utilization have declined over the past year.

Read More »

A Retrospective Descriptive Study of Remdesivir Treatment in the Home or Outpatient Setting Among Adult Patients Diagnosed with Coronavirus Disease 2019 (COVID-19)

Full text | Download pdf

Julia K. Nguyen, PharmD Kaiser Permanente, Southern California Home Infusion Pharmacy | Rulin Hechter, MD, PhD, MS Kaiser Permanente, Department of Research and Evaluation, Southern California Permanente Medical Group, Kaiser Permanente Bernard J. Tyson School of Medicine, Department of Health Systems Science | Deborah Ling Grant, PhD, MPH, MBA Kaiser Permanente Department of Research and Evaluation, Southern California Permanente Medical Group | Jiaxiao Shi, PhD Kaiser Permanente Department of Research and Evaluation, Southern California Permanente Medical Group | Cecilia Portugal, MPH Kaiser Permanente Department of Research and Evaluation, Southern California Permanente Medical Group | William J. Towner, MD Kaiser Permanente Department of Research and Evaluation, Southern California Permanente Medical Group, Kaiser Permanente Bernard J. Tyson School of Medicine, Department of Health Systems Science, Kaiser Permanente Southern California Infectious Diseases Clinic

At the onset of the COVID-19 pandemic, early conflicting evidence complicated implementation of therapy.

Read More »

A Retrospective Quality Improvement Study of Pharmacist-Directed Vancomycin Dosing Among Adult Home Infusion Patients

Full text | Download pdf

Claire Meredith, PharmD, CarepathRx | Leita Frey, PharmD, BCPS, CarepathRx, | Shelby George, PharmD, CarepathRx | Megan K. Zielke, PharmD, BCCCP, CarepathRx

Vancomycin is widely used to treat gram-positive infections. Vancomycin therapy is accompanied by the clinical monitoring of trough levels in order to maintain therapeutic efficacy and patient safety.

Read More »

NHIA Releases 2024 Commercial Payor Recommendations

The National Home Infusion Association (NHIA) has developed recommendations for commercial, Medicaid, and Medicare Advantage payors to improve patient outcomes and experience, reduce administrative burden, and improve timely access to home infusion services.

Read More »

Home Parenteral Nutrition Patient Experience and Clinical Outcomes

Full text | Download pdf

Michelle Simpson, PharmD, BCSCP, MWC, Clinical Program Manager and Editor-in-Chief, Infusion Journal at National Home Infusion Association; Danell Haines, PhD, D.J., Haines Research Consulting

Parenteral nutrition is a complex infusion therapy that impacts a patient’s health and well-being. The National Home Infusion Foundation (NHIF) collects data on the home parenteral nutrition (HPN) patient population. Quality measures monitored through two NHIF benchmarking programs provide data from patient satisfaction surveys and rates of hospital readmission within the first 30 days of home infusion services.

Read More »

NHIF Announces Finalists for 2024 Outstanding Abstract Achievement Award

The National Home Infusion Foundation (NHIF) announces the finalists for its Outstanding Abstract Achievement Award for 2024. The authors of the following 5 poster abstracts will present an overview of their research project and summarize their findings during a special clinical webinar and a panel of judges will select the award recipient.

Read More »

NHIA Announces 2024-2025 Board of Directors

The National Home Infusion Association (NHIA) is proud to announce its 2024-2025 Board of Directors. Beginning this term, the association expanded to 17 the number of board seats on its governing body to provide a broader diversification of infusion provider organizations.

Read More »

NHIA Announces 2024 Class of Fellows

The National Home Infusion Association (NHIA) is pleased to announce the 2024 Fellow Program (FNHIA) cohort, made up of highly accomplished home and alternate site infusion professionals.
The prestigious NHIA Fellow Program aims to advance the home and alternate site infusion profession by recognizing the contributions and achievements of highly accomplished individuals.

Read More »